PMID- 16079154 OWN - NLM STAT- MEDLINE DCOM- 20051101 LR - 20210915 IS - 0950-1991 (Print) IS - 1477-9129 (Electronic) IS - 0950-1991 (Linking) VI - 132 IP - 17 DP - 2005 Sep TI - Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin. PG - 3923-33 AB - Epithelial-mesenchymal crosstalk is essential for tissue morphogenesis, but incompletely understood. Postnatal mammary gland development requires epidermal growth factor receptor (EGFR) and its ligand amphiregulin (AREG), which generally must be cleaved from its transmembrane form in order to function. As the transmembrane metalloproteinase ADAM17 can process AREG in culture and Adam17(-/-) mice tend to phenocopy Egfr(-/-) mice, we examined the role of each of these molecules in mammary development. Tissue recombination and transplantation studies revealed that EGFR phosphorylation and ductal development occur only when ADAM17 and AREG are expressed on mammary epithelial cells, whereas EGFR is required stromally, and that local AREG administration can rescue Adam17(-/-) transplants. Several EGFR agonists also stimulated Adam17(-/-) mammary organoid growth in culture, but only AREG was expressed abundantly in the developing ductal system in vivo. Thus, ADAM17 plays a crucial role in mammary morphogenesis by releasing AREG from mammary epithelial cells, thereby eliciting paracrine activation of stromal EGFR and reciprocal responses that regulate mammary epithelial development. FAU - Sternlicht, Mark D AU - Sternlicht MD AD - Department of Anatomy, University of California, 513 Parnassus Ave., San Francisco, CA 94143-0452, USA. sternli@itsa.ucsf.edu FAU - Sunnarborg, Susan W AU - Sunnarborg SW FAU - Kouros-Mehr, Hosein AU - Kouros-Mehr H FAU - Yu, Ying AU - Yu Y FAU - Lee, David C AU - Lee DC FAU - Werb, Zena AU - Werb Z LA - eng GR - P50 CA058207-15/CA/NCI NIH HHS/United States GR - U01 ES012801-02/ES/NIEHS NIH HHS/United States GR - R01 CA061896/CA/NCI NIH HHS/United States GR - CA58207/CA/NCI NIH HHS/United States GR - R01 CA085410/CA/NCI NIH HHS/United States GR - ES012801/ES/NIEHS NIH HHS/United States GR - P50 CA058207/CA/NCI NIH HHS/United States GR - U01 ES012801/ES/NIEHS NIH HHS/United States GR - R01 CA061896-06/CA/NCI NIH HHS/United States GR - CA85410/CA/NCI NIH HHS/United States GR - R01 CA057621/CA/NCI NIH HHS/United States GR - CA57621/CA/NCI NIH HHS/United States GR - R01 CA085410-01/CA/NCI NIH HHS/United States GR - R01 CA057621-07/CA/NCI NIH HHS/United States GR - CA61896/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. DEP - 20050803 PL - England TA - Development JT - Development (Cambridge, England) JID - 8701744 RN - 0 (Amphiregulin) RN - 0 (Areg protein, mouse) RN - 0 (EGF Family of Proteins) RN - 0 (Glycoproteins) RN - 0 (Intercellular Signaling Peptides and Proteins) RN - 0 (Ligands) RN - 21820-51-9 (Phosphotyrosine) RN - EC 2.7.10.1 (ErbB Receptors) RN - EC 3.4.24.- (ADAM Proteins) RN - EC 3.4.24.- (Metalloendopeptidases) RN - EC 3.4.24.86 (ADAM17 Protein) RN - EC 3.4.24.86 (Adam17 protein, mouse) SB - IM EIN - Development. 2006 Mar;133(6):1203 MH - ADAM Proteins MH - ADAM17 Protein MH - Amphiregulin MH - Animals MH - Cells, Cultured MH - EGF Family of Proteins MH - Epithelial Cells/metabolism MH - ErbB Receptors/genetics/*metabolism MH - Female MH - Gene Expression Profiling MH - Gene Expression Regulation, Developmental MH - Glycoproteins/deficiency/genetics/*metabolism/pharmacology MH - Intercellular Signaling Peptides and Proteins/deficiency/genetics/*metabolism/pharmacology MH - Ligands MH - Mammary Glands, Animal/*embryology/growth & development/*metabolism MH - Metalloendopeptidases/genetics/*metabolism MH - Mice MH - Mice, Knockout MH - Morphogenesis/drug effects MH - Organoids/metabolism MH - *Paracrine Communication MH - Phosphorylation MH - Phosphotyrosine/metabolism MH - Stromal Cells/*metabolism PMC - PMC2771180 MID - NIHMS153480 EDAT- 2005/08/05 09:00 MHDA- 2005/11/03 09:00 PMCR- 2009/11/01 CRDT- 2005/08/05 09:00 PHST- 2005/08/05 09:00 [pubmed] PHST- 2005/11/03 09:00 [medline] PHST- 2005/08/05 09:00 [entrez] PHST- 2009/11/01 00:00 [pmc-release] AID - dev.01966 [pii] AID - 10.1242/dev.01966 [doi] PST - ppublish SO - Development. 2005 Sep;132(17):3923-33. doi: 10.1242/dev.01966. Epub 2005 Aug 3.